MyoKardia
MYOK
MYOK was delisted on the 16th of November, 2020.
73 hedge funds and large institutions have $196M invested in MyoKardia in 2017 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 26 increasing their positions, 16 reducing their positions, and 9 closing their positions.
89% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 9
63% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 16
3% more funds holding
Funds holding: 71 → 73 (+2)
0.59% less ownership
Funds ownership: 47.92% → 47.33% (-0.59%)
5% less capital inflows, than outflows
Capital inflows: $16.5M | Capital outflows: $17.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$4.48M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.58M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.51M |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$910K |
| 5 |
JP Morgan Chase
New York
|
+$820K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.97M |
| 2 |
Cormorant Asset Management
Boston,
Massachusetts
|
-$4.04M |
| 3 |
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.08M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$869K |
| 5 |
Millennium Management
New York
|
-$623K |
MYOK Hedge Fund Activity: Q1 2017 in Review
73 of the 4,036 institutional investors tracked by Wall St. Rank reported a position in MyoKardia (MYOK) for Q1 2017, worth a combined $196M — up 0.26% from $195M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new MYOK positions and 9 closed out — a net gain of 8 holders — while 26 added to existing stakes and 16 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $4.48M. The largest seller was Fidelity Investments, cutting an estimated $7.97M.
- 73 institutional investors held MyoKardia (MYOK) as of Q1 2017, up from 71 in Q4 2016.
- Funds reported $196M of MyoKardia stock for Q1 2017, up 0.26% quarter-over-quarter.
- 17 funds opened new MyoKardia positions in Q1 2017 and 9 closed out, a net change of +8 holders.
- The largest MyoKardia buyer in Q1 2017 was Wellington Management Group, an estimated $4.48M added.
- The largest MyoKardia seller in Q1 2017 was Fidelity Investments, an estimated $7.97M sold.
Based on aggregated 13F filings for Q1 2017.